Cancer Biomarker Market 2018; Booming CAGR of 15.8% by Major Types, Technology and Trends Forecast -2023

Market Research Future published a Cooked Research Report on Cancer biomarker Market. Cancer biomarker Market is Expected to Grow at a CAGR of ~15.8% by 2023.

Cancer biomarker Market Highlights:

Biomarkers discovery has become crucial as these play a key role in the early diagnosis of cancer, which increases the survival rates by enabling an early treatment. Clinical trials use metabolomics, imaging, and other innovative technologies to trace oncology biomarkers using proteins and genes. 

Get Exclusive Sample Report @ https://www.marketresearchfuture.com/sample_request/5378

The growth of this market is backed by the increasing prevalence of cancer, rising investment in oncology research, technological advancement, increasing use of cancer biomarker in drug discovery & development and Food and Drug Administration (FDA) support for the development of biomarker. 

The global cancer biomarker market is expected to grow at a CAGR of 15.8% during the forecast period, 2017-2023.

Cancer biomarker Market Scenario:

The cancer biomarker market is primarily driven by factors including adoption of western lifestyles in the developing regions, extensive research of cancer biomarkers, encouragement for biomarker development by FDA, improved precision and speed of diagnosis, high investment through government and private funds in cancer-related research, and development of highly specific drugs. According to WHO, it is anticipated to further increase over the next two decades by 70% with 22 million new cancer cases in 2012.

There are high investments and low benefit-cost ratio associated with the development of cancer biomarkers which is making it one of the major restraints of cancer biomarkers market.

The global cancer biomarker market is expected to grow at a CAGR of 15.8% during the forecast period, 2017-2023.

Key Players in Global Cancer Biomarker Market:

Some of key the players in the market are  F. Hoffmann-La Roche AG (Switzerland), Becton Dickinson (U.S.), Abbott Laboratories (U.S.), PerkinElmer, Inc. (U.S.), Bristol-Myers Squibb (U.S.), Bio-Rad Laboratories (U.S.), Eli Lilly and Company (U.S.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), GlaxoSmithKline plc. (U.S.), QIAGEN N.V (U.S.), Novartis AG (Switzerland), Thermo Fisher Scientific Inc. (U.S.), Illumina Inc. (U.S.)

Cancer biomarker Market Segmentation:

The global cancer biomarker market is segmented on the basis of types, applications and end users.

On the basis of types, the market is segmented into protein biomarker, genetic biomarker and others

On the basis of application, the market is segmented into diagnostic, prognostic and therapeutic. The diagnostic sub-segment is further classified into imaging and non- Imaging.

On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, diagnostic tool companies, healthcare it/big data companies, clinical laboratories

Get Your Customized Report @ https://www.marketresearchfuture.com/reports/cancer-biomarker-market-5378

Cancer biomarker Market Intended Audience:

Pharmaceutical Companies

Government and private research companies

Research and Development (R&D) Companies

Drug Manufacturers and Suppliers

Medical Research Laboratories 

Cancer biomarker Market Regional Analysis:

The global cancer biomarker market consists of four major regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa.

America holds the largest market share in the cancer biomarker market owing to increasing prevalence of cancers in the U.S. and Canada. Growing prevalence of malignancies coupled with increasing focus on development of targeted therapies is a major factor affirming positive growth of this market. North America dominated the regional segment followed closely by Europe. High adoption of innovative technology, presence of key pharmaceutical companies, established R&D infrastructure pertaining to the development of novel diagnostic products and increased demand for specific & early diagnostics are the major factors for aforementioned dominance.

In Europe, Germany, the U.K, and France are the largest contributors to the market owing to the availability of funds for research, and extensive research and development activities in oncology.

In Asia Pacific, India, and China are the fastest developing regions in the market owing to an overall demand for early diagnostic and treatment services, and increasing expenditure on primary care services across Asia Pacific.  However, the Asia Pacific region owing to increasing prevalence of cancer, beneficial environment for clinical trials, and increasing government funding for supporting drug development programs is anticipated to witness lucrative CAGR over the forecast period.

The Middle East & Africa exhibit steady but positive growth owing to low technology penetration in developing regions of Africa, and increasing demand for diagnostics services in developing regions. In the Middle East, the United Arab Emirates accounts for the largest market share for cancer biomarker market. 

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5 Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

TOC Continued…!

Get Discount @ https://www.marketresearchfuture.com/check-discount/5378

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.